Showing 1621-1630 of 2526 results for "".
- Bausch + Lomb Initiates First Clinical Trial for Technolas Teneo Excimer Laser in the United Stateshttps://modernod.com/news/bausch-lomb-initiates-first-clinical-trial-for-technolas-teneo-excimer-laser-in-the-united-states/2479560/Bausch + Lomb announced that it has initiated the first in a series of U.S. clinical trials to evaluate the safety and efficacy of the Technolas Teneo excimer laser for vision correction surgery for myopia and myopic astigmatism. “This is an exciting milestone for our organization, as it’s
- New Age-Related Macular Degeneration Common in Untreated Fellow Eyeshttps://modernod.com/news/new-age-related-macular-degeneration-common-in-untreated-fellow-eyes/2476748/New age-related macular degeneration (AMD) develops in about a quarter of fellow eyes to those treated for neovascular AMD with intravitreal anti-VEGF agents, according to a post hoc analysis of the VIEW 1 and VIEW 2 studies, as reported b
- EyecareLive Unveils Enhanced Responsible Telemedicine Platform for Optometry and Ophthalmologyhttps://modernod.com/news/eyecarelive-unveils-enhanced-responsible-telemedicine-platform-for-optometry-and-ophthalmology/2476674/EyecareLive announced the release of EyecareLive 2.0. EyecareLive was built by doctors, for doctors, with a mission to strengthen the doctor-patient relationship by providing a comprehensive telemedicine platform that enhances patient care. The launch will also feature EyecareLive’s
- Bausch + Lomb Ultra Multifocal for Astigmatism Contact Lenses Now Available In the United Stateshttps://modernod.com/news/bausch-lomb-ultra-multifocal-for-astigmatism-contact-lenses-now-available-in-the-united-states/2476671/Bausch + Lomb announced the US launch of Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses. The new monthly silicone hydrogel lens, which was specifically designed to address the lifestyle and vision n
- Goldman Sachs Unit to Buy 575 Optometry Practices in $2.7 Billion Dealhttps://modernod.com/news/report-goldman-sachs-unit-to-buy-capital-vision-services-in-2-7-billion-deal/2476625/In one of the largest optometry deals to date, the merchant-banking division of Goldman Sachs Group (West Street Capital Partners VII) announced that it is buying Capital Vision Services, which operates 575 optometry practices, from private-equity firm Altas Partners LP and Canadian pension fund
- New Biomarker Research Builds Furthers Understanding of Tebentafusp Mechanism of Action in Advanced Melanomahttps://modernod.com/news/new-biomarker-research-builds-furthers-understanding-of-tebentafusp-mechanism-of-action-in-advanced-melanoma/2476624/Monotherapy treatment with the first-in-class ImmTAC molecule tebentafusp (IMCgp100) induced an immunologically potent response in patients with advanced uveal and cutaneous melanoma, according to new data presented today by Immunocore Limited at the 2019 American Society of Clinical Oncology (AS
- Biophytis Files Registration Statement for Proposed Initial Public Offering in the United Stateshttps://modernod.com/news/biophytis-files-registration-statement-for-proposed-initial-public-offering-in-the-united-states/2476604/Biophytis announced that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) in relation to a proposed initial public offering of American Depositary Shares representing ordinary shares of Biophytis. Biophytis has applied to list its shares
- Nick Mamalis, MD, Named 2019 ASCRS President as ASCRS Unveils New Brandinghttps://modernod.com/news/nick-mamalis-md-named-2019-ascrs-president-as-ascrs-unveils-new-branding/2476560/Nick Mamalis, MD, a well-known ophthalmologist and longtime co-editor of the Journal of Cataract & Refractive Surgery, assumed his role as president of the American Society of Cataract and Refractive Surgery (ASCRS) during the ASCRS meeting’s opening general session here this p
- Testosterone May Underlie Rare Blindness Condition in Womenhttps://modernod.com/news/testosterone-may-underlie-rare-blindness-condition-in-women/2476435/A disease that causes chronic headaches and even blindness in women, and has puzzled researchers for more than 100 years, may be caused by excess androgens, particularly testosterone, that modulate secretion of cerebrospinal fluid (CSF), UK investigators have discovered, according to a
- University of Alberta Scientists Pinpoint a Cause of Pigmentary Glaucomahttps://modernod.com/news/university-of-alberta-scientists-pinpoint-a-cause-of-pigmentary-glaucoma/2476337/An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition. “People who traditionally we wouldn’t think of having glaucoma—young males in their 20s and 30s—are at particular risk